Published: October 2023
Driven by the rise in popularity of cell therapies, there is a growth in demand for cell culture media, reagents and surfaces. It is worth mentioning that, amidst the increasing demand for such products, there is a rise in stringency from regulatory authorities to ensure that the quality of raw materials is good. Therefore, to meet the industry needs, cell therapy manufacturers are actively adopting serum free and xeno free products, which are known to reduce the risk of batch-to-batch variability. We analyzed more than 80 industry players that offer more than 450 cell therapy consumable products. In this article, discover top 5 cell culture media providers.
Since the development of the first cell therapy, this therapeutic segment has garnered significant attention from researchers and medical practitioners. This can be attributed to the fact that cell therapies have been demonstrated to possess a vast potential in the treatment of rare disorders, which were previously considered incurable. The popularity of this therapeutic class of products can also be validated from the fact that, since 2019, more than 1,000 clinical trials focused on cell therapies have been initiated. It is also worth mentioning that over 35 cell and gene therapy candidates have already been commercialized, across various geographical locations, till date.
However, the marketed cell-based therapies are exorbitantly priced. Even though, with the introduction of automation technologies in cell therapy bioprocessing, the cost and time required for development of such products has reduced significantly, there is still a considerable scope of improvement to make these therapies affordable. In this context, it is worth mentioning that consumables, including media, reagents and matrices, currently constitute nearly 25% of the overall cost of cell therapy manufacturing. Optimization of raw materials, by streamlining the production processes, can help mitigate wastage and further reduce the manufacturing cost. Moreover, for commercial applications, it is crucial to obtain consistent outcomes during the manufacturing process. Cell culture media, with chemically defined formulation, provides enhanced consistency for production purposes.
Roots Analysis has conducted an exhaustive study on Cell Therapy Media, Kits, Reagents and Surfaces Market featuring the current market landscape of current market landscape and the likely future potential of the cell culture media (supplied alone or in kits as a combination with cell growth supplements), cell culture reagents and ECM market, over the forecast period 2023-2035.
Below, we have listed (in alphabetical order), the top 5 cell culture media providers, based on their product portfolio / capabilities.
| Company | Year of Establishment | Headquarters | Employee Count |
| Irvine Scientific | 1970 |  |
501-1,000 |
| Lonza | 1897 | .webp) |
10,001+ |
| Sartorius | 1870 | .webp) |
10,001+ |
| STEMCELL Technologies | 1993 |  |
1,001-5,000 |
| Thermo Fisher Scientific | 1956 | .webp) |
10,001+ |
Interested in exploring all 450+ Cell Culture Media, Kits, Reagents and Extracellular Matrices available for cell therapy manufacturing?
 |
Irvine Scientific is a US based company that claims to be a global leader in the manufacturing of cell culture media, reagents and medical devices. In June 2018, the firm was acquired by FUJIFILM, with an aim to expand its contract development and manufacturing business, and to accelerate research and development in the field of regenerative medicine. According to the company’s website, it offers a wide range of services, ranging from media optimization to its commercial production.
The following table presents the details on the cell culture media products offered by Irvine Scientific:
| Parameter | Description |
| Number of Facility | 2 |
| Location of Consumables Manufacturing Facility |
|
| Cell Culture Media Compatibility |
|
| Type of Cell Therapy |
The company offers consumable services for the following cell therapies:
|
| Application Area |
|
Recent Initiatives Undertaken by Irvine Scientific:
 |
Lonza is a Swedish company, which claims to be a one-stop solution for its consumers in the healthcare sector. As per the firm’s website, it is engaged in providing innovative healthcare solutions to its clients across the globe. Additionally, it provides a broad range of products, including small molecules, biologics, cell and gene therapies, pharmaceutical APIs and formulations. Further, the firm provides cell and gene therapy solutions that are cGMP compliant, in order to minimize the risks and challenges associated with scaleup and commercialization of these therapies.
The following table presents the details on the cell culture media products offered by Lonza:
| Parameter | Description |
| Number of Facility | 3 |
| Location of Consumables Manufacturing Facility |
|
| Cell Culture Media Compatibility |
|
| Type of Cell Therapy |
The company offers consumable services for the following cell therapies:
|
| Application Area |
|
Recent Initiatives Undertaken by Lonza:
 |
Sartorius is a Germany based company that claims to have the required expertise in the domain of life sciences. The firm’s business operations span across two segments, namely bioprocess solutions, lab products and services. Further, it states to provide the aforementioned solutions through its two subsidiaries, namely Sartorius Lab and Sartorius Stedim Biotech.
The following table presents the details on the cell culture media products offered by Sartorius:
| Parameter | Description |
| Number of Facility | 2 |
| Location of Consumables Manufacturing Facility |
|
| Cell Culture Media Compatibility |
|
| Type of Cell Therapy |
The company offers consumable services for the following cell therapies:
|
| Application Area |
|
Recent Initiatives Undertaken by Sartorius:
 |
STEMCELL Technologies is a Canada based company that claims to have the required expertise related to the development of high-quality cell culture media, instruments and auxiliary products, in order to support research across various therapeutic areas, including immunology, oncology and regenerative medicine. At present, the product portfolio of the company features over 2,500 premium quality products. As per the firm’s website, it has established operations across 25 countries, along with several distribution networks, to with an aim to cater to customers located across the globe.
The following table presents the details on the cell culture media products offered by STEMCELL Technologies:
| Parameter | Description |
| Number of Facility | 1 |
| Location of Consumables Manufacturing Facility |
|
| Cell Culture Media Compatibility |
|
| Type of Cell Therapy |
The company offers consumable services for the following cell therapies:
|
| Application Area |
|
Recent Initiatives Undertaken by STEMCELL Technologies:
 |
Thermo Fisher Scientific is a US based company that offers integrated products / solutions in the domain of life sciences, clinical diagnostics, industrial and applied sciences. Additionally, it provides a complete suite of cell therapy solutions, including ancillary materials, for stem cell research, manufacturing, and clinical trial assistance. It is worth highlighting that the consumables offered by the company have been used in over 200 clinical trials.
The following table presents the details on the cell culture media products offered by Thermo Fisher Scientific:
| Parameter | Description |
| Number of Facility | 4 |
| Location of Consumables Manufacturing Facility |
|
| Cell Culture Media Compatibility |
|
| Type of Cell Therapy |
The company offers consumable services for the following cell therapies:
|
| Application Area |
|
Recent Initiatives Undertaken by Thermo Fisher Scientific:
The above presentation features top cell culture media providers selected from a pool of over 80 companies offering more than 450 cell therapy consumables that we have compiled. If you're interested, you can download the Sample Report on this topic by Roots Analysis. For personalized assistance in identifying the most relevant solutions based on your specific criteria, please don't hesitate to reach out to us at sales@rootsanalysis.com.
With an experience of over 4 years with Roots Analysis, Jasmeet is adept at generating useful insights from unstructured / structured datasets. As a senior analyst at Roots Analysis, she has assisted several clients across multiple industry verticals within the healthcare industry. These verticals include contract services, devices / technologies, and drugs / disease indications. Since the findings of the research are aimed at supporting the clients to make thoughtful decisions for their business, she has hands-on experience on competitive landscape assessment, benchmarking, market sizing and forecasting, as well as several quantitative / qualitative / strategic frameworks.
Source 1: https://www.lonza.com/media-advisories/2023-05-16-14-00#:~:text=Lonza's%20new%20GMP%2Dgrade%20medium,regulatory%20approval%2C%20and%20therapy%20production.
Source 2: https://www.sartorius.com/en/company/newsroom/corporate-news/sartorius-establishes-competence-center-for-manufacturing-components-for-cell-and-gene-therapies-in-freiburg-1475858#page_35540=2
Source 3: https://www.sartorius.com/en/company/newsroom/corporate-news/sartorius-completes-acquisition-of-polyplus-1454004
Source 4:https://www.businesswire.com/news/home/20230628528159/en/Thermo-Fisher-Scientific-Introduces-Tumoroid-Culture-Medium-to-Accelerate-Development-of-Novel-Cancer-Therapies
MEDIA CITATIONS
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry
SUBSCRIBE TO INDUSTRY UPDATES
.png)
